4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000899243-16-019287
President and CEO acquired 27,096 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Brady Todd C President and CEO | 2016-05-03 | Grant or award | +27,096 | 42,185 | D |
Loading xslF345X03/doc4.xml…